with the wild-type enzyme, resistance against subsequent neurological controls, 54 sporadic and 12 familial ALS proteolytic steps and/or a compromised downstream cases, and 10 cases homozygous for the D90A mutation. proteolytic machinery. Molecular fragments accumulated Three cases heterozygous for the A89V, S105L and G114A to a greater extent from the D90A mutant enzyme might CuZn-SOD mutations showed low amounts of CuZncontribute to the motor neurone degeneration. We also SOD. There was no evidence for accumulation of inactive determined the other SOD isoenzymes: in the controls, protein in any of the groups. Immunoblots showed no CuZn-SOD contributed 75%, extracellular SOD 25% and evidence for the presence of any precipitates or other Mn-SOD Ͻ5% of the total SOD activity. There was no molecular forms of CuZn-SOD with higher molecular difference in the amount of extracellular SOD between any of the groups. weight in the groups. About 25% of the CuZn-SOD
Introduction

Amyotrophic lateral sclerosis (ALS) is a fatal
CuZn-SOD activity in erythrocytes (Deng et al., 1993) , other cell types (Tsuda et al., 1994) and CNS tissue (Bowling neurodegenerative syndrome characterized by adult-onset progressive loss of motor neurones in the motor cortex, et al., 1995) . The D90A CuZn-SOD mutation shows some deviant features. Some 80 cases, apparently sporadic or brainstem and medulla spinalis causing muscular wasting, paresis and inevitable death. About 10% of ALS cases are members of some 20 different families, homozygous for the mutation have been found up to now (Andersen et al., 1996; familial (FALS) (Haverkamp et al., 1995) and in~20% of these the disease has been associated with mutations in Boukaftane et al., 1998) . The disease in these recessive cases shows a milder phenotype (Andersen et al., 1996) , and the the CuZn-superoxide dismutase (SOD, EC 1.15.1.1) gene (Andersen et al., 2000) . About 90 different mutations have CuZn-SOD activity is essentially normal in erythrocytes. The mechanism by which the CuZn-SOD mutations cause motor been identified, with all but one showing a dominant pattern of heredity, and in most cases a significant reduction in neurone degeneration is not understood, but the collective evidence (Gurney et al., 1994; Andersen et al., 1995 ; Reaume polyacrylamide; Bio-Rad, Hercules, Calif., USA) and electroblotted onto polyvinylidine difluoride membranes et al., 1996) suggests a toxic gain of function rather than loss of function.
(Amersham Pharmacia Biotech, Uppsala, Sweden). Blots were probed with antibodies and chemiluminescence was In some other neurodegenerative diseases, such as Alzheimer's disease (Goate et al., 1991) , Parkinson's disease generated using Supersignal West Dura substrate (Pierce, Rockford, Ill., USA). Bands were visualized on film or by (Polymeropoulus et al., 1997) and Creutzfeld-Jacob's disease (Prusiner et al., 1998) , the protein mutated in inherited cases using a Fluor-S Multiimager and Quantity One software (Bio-Rad, Hercules, Calif., USA). The primary antibodies is also involved in the disease in sporadic cases. Furthermore, alterations in the molecular forms of the proteins can be used were polyclonal rabbit antibodies raised against keyhole limpet haemocyanin-coupled peptides corresponding to demonstrated, and these seem to be involved in the disease processes. A similar situation may pertain to ALS. A way to amino acids 3-20, 24-39, 43-57, 58-72, 80-96, 100-115 and 131-153 in the human CuZn-SOD sequence. The rabbit mirror the CNS is to analyse the CSF. In the present study, we determined the amounts, activities and molecular forms antisera were purified on protein A-Sepharose (Amersham Pharmacia Biotech, Uppsala, Sweden) followed by of CuZn-SOD in CSF from 10 homozygous ALS cases, one case heterozygous for the D90A mutation, three cases purification on a Sulfolink coupling gel (Pierce, Rockford, Ill., USA) with the corresponding coupled peptides. Secondary heterozygous for other mutations, and 12 FALS and 54 sporadic ALS (SALS) cases not carrying such mutations, antibodies were horseradish peroxidase-labelled anti-rabbit IgG antibody or biotinylated anti-rabbit IgG antibody and and compared them with 37 neurological controls.
horseradish peroxidase-labelled streptavidin (Amersham Pharmacia Biotech, Uppsala, Sweden).
Material and methods
Patients and controls
CSF was collected from 54 SALS and 12 FALS cases without CuZn-SOD mutations, 10 homozygous ALS cases, one ALS
Results
case heterozygous for the D90A CuZn-SOD mutation, and
Activities and amounts of SOD isoenzymes
one case each heterozygous for the A89V, S105L and The results of the quantitative SOD isoenzyme activity and G114A mutations. Thirty-seven cases with headache or other protein analyses are summarized in Table 1 . In the controls, neurological symptoms for which no underlying neurological almost all the SOD activity was cyanide sensitive, i.e. disease could be diagnosed served as controls. All ALS produced by CuZn-SOD and EC-SOD. Using the specific cases were genotyped for CuZn-SOD mutations as described activities for CuZn-SOD and EC-SOD, it can be calculated (Andersen et al., 1997) . After tapping, the samples were from the ELISA data that the former accounts for 73% of immediately frozen and kept at -80°C. The patients' consent the SOD activity and the latter 23%. Regarding the low was obtained according to the declaration of Helsinki and cyanide-resistant SOD activity, which is produced by the the study was approved by the medical research ethics mitochondrial Mn-SOD, it should be noted that the SOD committee at Umeå University.
assay is 10-fold less sensitive for that activity than for the cyanide-sensitive isoenzymes (Marklund, 1976 (Marklund, , 1985 . Mn-SOD may account for up to 5% of the SOD activity of
SOD analysis
control CSF. The SOD activity was determined with the potassium super-
The amounts of CuZn-SOD were greater in the SALS and oxide assay, and 3 mM cyanide was used for the distinction FALS cases without CuZn-SOD mutations than in the controls between the sensitive CuZn-SOD and extracellular SOD and the D90A homozygous FALS group. These differences (EC-SOD), and the resistant manganese-SOD (Mn-SOD) appear to be explained by the greater ages in the SALS and (Marklund, 1976 (Marklund, , 1985 . CuZn-SOD protein and EC-SOD FALS groups and the increases with age in the amount of protein were determined with enzyme-linked immunoCuZn-SOD in the CSF seen in these groups (r 2 ϭ 0.18, sorbent assay (ELISA). The activities of these isoenzymes P Ͻ 0.01 and r 2 ϭ 0.27, P Ͻ 0.09, respectively) ( Fig. 1 ). It were calculated from their specific activities, 4.4 ng/U for is apparent from this figure that there is no difference in the CuZn-SOD and 8.6 ng/U for EC-SOD. The D90A mutant amount of mutant CuZn-SOD in the D90A homozygous CuZn-SOD shows a lower reactivity in the ELISA, 2.9 ng/U FALS group and of wild-type enzyme in the ALS cases not (Andersen et al., 1998) .
carrying CuZn-SOD mutations. The amounts of CuZn-SOD The CSF protein content was determined with a Coomassie in the A89V, S105L and G114A heterozygotes were roughly brilliant blue G-250 assay, standardized with human serum half those seen in other ALS cases (Table 1 ). The single albumin.
D90A heterozygote also showed a low activity. There was no difference in the amount of EC-SOD between the three groups. As a check for the internal consistency
Immunoblotting
The CSF samples were subjected to SDS-PAGE (sodium between the SOD activity and SOD protein assays, the combined calculated activities of CuZn-SOD and EC-SOD dodecylsulphate-polyacrylamide gel electrophoresis, 12% SOD enzymic activity was determined with the potassium superoxide assay. CuZn-SOD and EC-SOD protein were determined by ELISA, and the corresponding enzymic activities were calculated using the specific activities of the isoenzymes; see Material and methods. The ratios between the sum of these activities and the measured cyanide-sensitive activities were calculated for all patients, as a check for the internal consistency of the various assays. The data are presented as means Ϯ standard deviation. One-way ANOVA (analysis of variance) with Tukey's honestly SD post hoc test found no significant differences between any of the groups. Pair-wise comparison with the Mann-Whitney non-parametric U test found the total SOD activity of the controls to be significantly lower than that of the SALS and FALS groups, P Ͻ 0.015 and P Ͻ 0.014, respectively. The CuZn-SOD activities in the controls and D90A homozygotes were significantly lower than in the FALS group, P Ͻ 0.05 and P Ͻ 0.017, respectively. part of the gels. As previously demonstrated (Marklund et al., 1997) , the D90A mutant showed a higher mobility than the wild-type enzyme ( Fig. 2A) . The major novel finding was a relatively strong band with an apparent molecular weight 2.5 kDa lower than that of the full-length subunit, which was seen in all the analysed CSF samples. A band with a similar mobility is also found regularly in CNS extracts, but is barely visible. It could be visualized with all antipeptide antibodies except that directed against amino acids 3-20 in the CuZn-SOD sequence, suggesting that it represents a subunit truncated in the N-terminal end (Fig. 2B ). There was no difference in the amount of the low-molecular weight band between CSF samples that had been divided into one part controls, SALS and FALS cases, but it was considerably larger in the D90A mutant FALS cases ( Table 2 ). The were divided by the total measured cyanide-sensitive immunoblot of the D90A heterozygote CSF sample showed activities. These ratios were close to unity in all groups apparently equal amounts of the full-length subunits, and (Table 1 ). This finding also indicates that there were no truncated forms of both types of subunits appeared to be significant accumulations of inactive SOD protein in any of present. The samples from the heterozygous A89V, S105L the groups, at least as could be detected by the ELISAs. and G114A mutant ALS cases showed lower amounts of the full-length band (cf. Table 1) , and the relative amounts of the truncated bands appeared to be more similar to the ratios
Analysis by immunoblotting
seen in the D90A homozygotic samples. No other differences CSF from all cases carrying CuZn-SOD mutations was were found in immunoblots from these samples. analysed by immunoblotting and compared with nine controls, nine SALS and nine FALS cases, using two different antipeptide antibodies directed against amino acids 43-57
Discussion
The concentration of CuZn-SOD in CSF should be positively and 58-72. There was no evidence for the presence of aggregates in the stacking gel, or of smearing or other dependent on the concentration of the enzyme in the cytosol of cells in the CNS and the rates of basal background leakage evidence for high-molecular weight materials in the separation appear to be no differences in CuZn-SOD content between the controls, the ALS and FALS groups and the D90A homozygous FALS cases. Although there should be some increased leakage of CuZn-SOD from compromised motor neurones, the disease has a slow course and afflicts only a limited portion of the cells in the CNS. In more acute diseases such as stroke, afflicting a large portion of the CNS, several fold increases in the amount of CuZn-SOD in the CSF have been found (Strand and Marklund, 1992; Yoshida et al., 1994) The amount of mutant CuZn-SOD in CSF from patients carrying CuZn-SOD mutations has not been analysed previously. The present findings suggest that the content and activity of D90A mutant CuZn-SOD in CNS tissue are similar to those of controls and other ALS cases, in accordance with previous findings of a high activity in erythrocytes (Andersson et al., 1998) and a high stability of the isolated mutant enzyme (Marklund et al., 1997) . In addition to the common recessive D90A ALS families, several pedigrees with the D90A mutation and a dominant heredity have also been reported (reviewed in Andersen et al., 2000) . These dominant cases in general seem to have a more severe phenotype than that seen in the recessive cases. Haplotype analysis of families from around the world suggests that all recessive cases share carrying the wild-type enzyme, suggesting that it is not were no significant differences between the FALS and SALS cases and the controls.
involved in the disease in these cases. The analysis of the A89V, S105L and G114A heterozygotes indicated lowered amounts of CuZn-SOD, but the relative amounts of the lowand enhanced leakage from compromised cells, and inversely dependent on the rate of turnover of CSF. There was probably molecular weight portion tended to be high. In general, the CuZn-SOD activity is~50% of that of controls in CNS from no major alteration in CSF turnover or vascular permeability in the ALS groups since there was no significant alteration heterozygotes for ALS-linked mutations, owing to rapid degradation of the mutant protein (Bowling et al., 1995) . It in the amount of CSF protein compared with controls. Taking the differences in age between the groups into account, there is likely that the material seen in the immunoblots from these
